COLL Collegium Pharmaceutical Inc

Collegium Pharmaceutical Inc is a specialty pharmaceutical company which is engaged in developing and planning to commercialize abuse-deterrent products through its patented DETERx platform technology.

$19.80  +0.13 (0.66%)
As of 09/17/2021 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  05/07/2015
Outstanding shares:  35,564,465
Average volume:  224,812
Market cap:   $706,310,275
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    19459J104
ISIN:        US19459J1043
Sedol:      BX7RSN3
Valuation   (See tab for details)
PE ratio:   6.55
PB ratio:   2.76
PS ratio:   2.17
Return on equity:   42.18%
Net income %:   32.73%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy